U.S. FDA Grants Tentative Approval of Yutrepia (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

MORRISVILLE, N.C., Aug. 19, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that the U.S. Food and Drug...

Articles similaires

CT-Based Radiomics Nomogram Can ID RA-Linked Interstitial Lung Disease

drugs.com - 06/Sep 15:09

FRIDAY, Sept. 6, 2024 -- A computed tomography (CT)-based radiomics nomogram model can achieve favorable efficacy for predicting low-risk patients...

Interstitial Lung Disease Clinical Trials 2024: FDA Approvals, Medication, Pipeline Therapies, Mechanism of Action, Route of Administration, Companies by DelveInsight

mountaintoday.in - 15/Sep 07:17

Interstitial Lung Disease Clinical Trials Interstitial Lung Disease companies are AstraZeneca, CSL Behring, Syndax Pharmaceuticals, Taiho...

Unicycive Therapeutics Announces Submission of the New Drug Application (NDA) to the U.S. FDA for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis

drugs.com - 03/Sep 01:09

LOS ALTOS, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing...

Interstitial Cystitis Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest EMA, PDMA, FDA Approvals by DelveInsight | Merck & Co, Teva Pharmaceutical Industries, Integrative Therapeutics

mountaintoday.in - 04/Sep 07:57

Interstitial Cystitis market The Interstitial Cystitis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)....

Interstitial Cystitis Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest EMA, PDMA, FDA Approvals by DelveInsight | Merck & Co, Teva Pharmaceutical Industries, Integrative Therapeutics

mountaintoday.in - 04/Sep 07:57

Interstitial Cystitis market The Interstitial Cystitis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)....

How diet could help control high blood pressure in lungs

knowridge.com - 09/Sep 10:18

A new discovery by researchers at the University of Pittsburgh suggests that dietary changes could help treat pulmonary hypertension, a serious lung...

Interstitial Cystitis Clinical Trials 2024 (Updated): FDA Approvals, Medication, Pipeline, Therapies, Mechanism of Action, ROA and Companies by DelveInsight

mountaintoday.in - 15/Sep 08:16

Interstitial Cystitis Clinical Trials Interstitial Cystitis companies are Seikagaku Corporation, UCB, Alivio Therapeutics, Merck, Teva Pharmaceutical,...

Les derniers communiqués

Adobe Brings Conversational AI to Trillions of PDFs with the New AI Assistant in Reader and Acrobat
Adobe - 21/02/2024
Laura Frigenti takes the Helm as Chief Executive Officer of the Global Partnership for Education
Global Partnership for Education - 05/12/2022

Rubriques :

U.S. FDA Grants Tentative Approval of Yutrepia (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

Articles similaires

CT-Based Radiomics Nomogram Can ID RA-Linked Interstitial Lung Disease

Interstitial Lung Disease Clinical Trials 2024: FDA Approvals, Medication, Pipeline Therapies, Mechanism of Action, Route of Administration, Companies by DelveInsight

Unicycive Therapeutics Announces Submission of the New Drug Application (NDA) to the U.S. FDA for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis

Interstitial Cystitis Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest EMA, PDMA, FDA Approvals by DelveInsight | Merck & Co, Teva Pharmaceutical Industries, Integrative Therapeutics

Interstitial Cystitis Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest EMA, PDMA, FDA Approvals by DelveInsight | Merck & Co, Teva Pharmaceutical Industries, Integrative Therapeutics

How diet could help control high blood pressure in lungs

Interstitial Cystitis Clinical Trials 2024 (Updated): FDA Approvals, Medication, Pipeline, Therapies, Mechanism of Action, ROA and Companies by DelveInsight

Lung Complications + Rheumatoid Arthritis Increase Risk for Lung Cancer

Liquidia Technologies (LQDA) Soars 14.1%: Is Further Upside Left in the Stock?

Lung Function Stable Three Years After Hematopoietic Cell Transplant in Sickle Cell

Les derniers communiqués